Dr. Weyrich's Naturopathic Functional Medicine Notebook is a collection of information on topics of interest
to Dr. Weyrich that may be of interest to the world wide audience.
Due to limitations of time, not all information that Dr. Weyrich knows or would like to further research is
Dr. Weyrich welcomes financial contributions to support specific research topics, as well as copies of
non-free access journal articles for him to review on a topic.
Constructive criticism is also welcome.
Please see Cancer Overview for general information that is common to all forms of cancer.
Dr. Weyrich is not an expert in the treatment of cancer, but does offer supportive
therapies to reduce pain and nausea, mitigate the side effects, and to generally boost the immune system.
Complimentary and alternative treatments for colon cancer that are considered below include:
Low Dose Naltrexone
Etiology of Colon Cancer
[Friedman2013] has presented a compelling model for the prevention and treatment of breast and prostate cancer,
and pointed out that (properly administered with attention to suppressing conversion to estradiol and dihydrotestosterone),
testosterone is capable of killing colon cancer cells by promoting apoptosis [Gu2009], [Gu2011].
The differences between different types of cancers require further study.
Naturopathic, Complimentary and Alternative Treatments
Low Dose Naltrexone (LDN)
According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit
[LDN_Cancer] reports that the late Dr. Bernard Bihari treated approximately 450
patients with some form of cancer, with a 60% success rate, almost all of who had failed to
respond to standard treatments.
Dr. Weyrich has been trained in the use of Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of colon cancer with LDN.
According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit colon cancer.
It is believed that LDN works by temporarily blocking the body's opioid receptors, which induces a reflex increase in the body's natural
endorphin and enkephalin levels, which then target the tumors' opioid receptors and induce apoptosis (programmed cell death) of the cancer cells.
The endorphins and enkephalins also increase natural killer cells and other immune responses against the cancer cells [Mathews1983].
The main caveats are that patients cannot also be being treated with extended release opiates for pain control and cannot be organ transplant recipients.
This is an off-label use, and as such is not likely to be covered by insurance.
Dr. Weyrich has been trained in the use of Low Dose Naltrexone (LDN) and offers these protocols as a complement to other therapies;
however at this time Dr. Weyrich has not treated any cases of colon cancer.